I am a hematologist/oncologist whose primary research interest is in leukemia, myelodysplasia, and myeloproliferative disorders. My current research focus is on immune system manipulations for therapeutic effects in patients with relapsed and refractory blood cancers.
In the clinic, I see patients with both malignant and non-malignant blood disorders.
| Pando A, Reagan JL, Quesenberry P, Fast LD. "Extracellular vesicles in leukemia." Leukemia Research, vol. 64, 2018, pp. 52-60. |
| Pando, Alejandro, Reagan, John L., Nevola, Martha, Fast, Loren D. "Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells." Experimental Hematology & Oncology, vol. 7, no. 1, 2018, pp. 25. |
| Le A, Farmakiotis D, Reagan JL. "Pruritic Rash in a Patient with Hodgkin's Lymphoma." Cureus, vol. 10, no. 4, 2018, pp. e2450. |
| Sahin I, Reagan JL, Niroula R, Sweeney JD. "Refractoriness to red blood cell transfusion therapy due to hypersplenism." Transfusion, vol. 58, no. 11, 2018, pp. 2513-2516. |
| Egan, Pamela C, Reagan, John L. "The return of gemtuzumab ozogamicin: a humanized anti-CD33 monoclonal antibody–drug conjugate for the treatment of newly diagnosed acute myeloid leukemia." OncoTargets and Therapy, vol. Volume 11, 2018, pp. 8265-8272. |
| "Dysuria in a Patient With AIDS and Lymphoma." Clinical Infectious Diseases, vol. 65, no. 5, 2017, pp. 867-867. |
| Castillo JJ, Jurczyszyn A, Brozova L, Crusoe E, Czepiel J, Davila J, Dispenzieri A, Eveillard M, Fiala MA, Ghobrial IM, Gozzetti A, Gustine JN, Hajek R, Hungria V, Jarkovsky J, Jayabalan D, Laubach JP, Lewicka B, Maisnar V, Manasanch EE, Moreau P, Morgan EA, Nahi H, Niesvizky R, Paba-Prada C, Pika T, Pour L, Reagan JL, Richardson PG, Shah J, Spicka I, Vij R, Waszczuk-Gajda A, Gertz MA. "IgM myeloma: A multicenter retrospective study of 134 patients." American Journal of Hematology, vol. 92, no. 8, 2017, pp. 746-751. |
| Rafelson WM, Reagan JL, Fast LD, Lim SH. "Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?." Leukemia & lymphoma, vol. 58, no. 11, 2017, pp. 1-9. |
| Shallis RM, Rome RS, Reagan JL. "Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review." Clinical lymphoma, myeloma & leukemia, 2017. |
| Mantripragada KC, Rizk SF, Reagan JL, LeGolvan M. "Acquired Syphilis With Anemia and Leukoerythroblastic Reaction: A Case Report." Annals of Internal Medicine, vol. 165, no. 3, 2016, pp. 226-7. |
| Foderaro, A. E., Reagan, J. L. "Hodgkin lymphoma mimicking lung abscess." Blood, vol. 128, no. 25, 2016, pp. 3011-3011. |
| Foderaro AE, Reagan JL. "Hodgkin lymphoma mimicking lung abscess." Blood, vol. 128, no. 25, 2016, pp. 3011. |
| Castillo, Jorge J., Reagan, John L., Sikov, William M., Winer, Eric S. "Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma." British Journal of Haematology, vol. 169, no. 3, 2015, pp. 352-355. |
| Reagan, John L., Sullivan, Matthew R., Winer, Eric S., Lansigan, Frederick, Cardin, Michael S., Castillo, Jorge J. "Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study." Leukemia Research, vol. 39, no. 8, 2015, pp. 812-7. |
| Mantripragada K, Reagan JL, Quesenberry PJ, Fast LD. "Advances in cellular therapy for the treatment of leukemia." Discovery medicine, vol. 17, no. 91, 2014, pp. 15-24. |
| Reagan JL, Ingham RR 2nd, Dalia S, Butera JN, Sweeney JD. "Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testing." Thrombosis research, vol. 134, no. 1, 2014, pp. 90-2. |
| Chorzalska A, Salloum I, Shafqat H, Khan S, Marjon P, Treaba D, Schorl C, Morgan J, Bryke CR, Falanga V, Zhao TC, Reagan J, Winer E, Olszewski AJ, Al-Homsi AS, Kouttab N, Dubielecka PM. "Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia." Leukemia, vol. 28, no. 11, 2014, pp. 2165-77. |
| Reagan JL, Castillo JJ. "Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia." Future oncology (London, England), vol. 10, no. 7, 2014, pp. 1147-55. |
| Gavini A, Reagan JL, Winer ES, Castillo JJ. "Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always." American Journal of Hematology, vol. 89, no. 8, 2014, pp. 853-7. |
| Castillo JJ, Reagan JL, Bishop KD, Apor E. "Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies." British Journal of Haematology, vol. 165, no. 3, 2014, pp. 300-15. |
Leukemia and Lymphoma Society Special Fellow in Clinical Research Career Development Award, $195,0000, 7/1/2013
Center of Biomedical Research Excellence at Rhode Island Hospital, $50,000, 7/1/2013
Rhode Island Foundation Biomedical Research Grant, $25,000
Center of Biomedical Research Excellence at Rhode Island Hospital, $50,000, 7/1/2017
| Year | Degree | Institution |
|---|---|---|
| 2010 | MD | Upstate Medical University |
| 2000 | BA | Hamilton College |
| Name | Title |
|---|---|
| Butera, James | Clinical Associate Professor of Medicine |
| Dubielecka-Szczerba, Patrycja | Associate Professor of Medicine |
| Fast, Loren | Associate Professor Emeritus of Medicine |
| Liang, Olin | Assistant Professor of Medicine (Research) |
| Olszewski, Adam | Associate Professor of Medicine |
| Quesenberry, Matthew | Assistant Professor of Medicine, Clinician Educator |
| Quesenberry, Peter | Paul Calabresi, M.D. Professor of Oncology, Professor of Medicine |
| Safran, Howard | Professor of Medicine |
| Young, Carolyn | Clinical Assistant Professor of Pathology and Laboratory Medicine |
